Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma
Endometrial cancer is the most common gynecologic malignancy in the United States, with a prevalence of 25.7 per 100,000 women per year (Mahdy et al., 2023). Recurrences of endometrial carcinoma have a mean interval of occurring 2–3 years after primary treatment, with 64 % of cases occurring within...
| Main Authors: | Kathleen Lundeberg, Juliet Wolford, Thomas Reid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Gynecologic Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578924000699 |
Similar Items
-
An integrated prediction model of recurrence in endometrial endometrioid cancers
by: Miller MD, et al.
Published: (2019-06-01) -
Endometrioid endometrial cancer “recurring” as high-grade serous adenocarcinoma in the inguinal lymph nodes in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
by: Wei Jiang, et al.
Published: (2019-05-01) -
Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment?
by: Manolis Nikolopoulos, et al.
Published: (2021-11-01) -
Recurrence Pattern after Adjuvant Radiotherapy for Endometrioid Type Endometrial Cancer
by: Yasin Durmus, et al.
Published: (2018-08-01) -
Prognostic factors determining survival after extrapelvic recurrence in endometrioid type endometrial cancer
by: Fatih Kilic, et al.
Published: (2021-11-01)